An injection that regulates blood glucose levels causes a remission of type 2 diabetes in mice for a period of four months, according to a study published today by the journal Nature Medicine.
Type 2 diabetes, which appears mainly due to overweight and sedentary lifestyle, represents almost 90 % of cases and is suffering from those who do not produce sufficient amount of insulin or do not use it correctly.
Researchers from various American universities applied an FGF1 injection in rats and mice (Fibroblast growth factor 1), hormone involved in biological mechanisms, on the brain circuits responsible for regulating glucose.
After that they verified that the blood levels of this organic compound were normalized for at least four months, although for this a very powerful dose was needed repeatedly.
The scientist Michael W. Schwartz, from the University of Washington, in the United States, said that the antidiabetic effect does not aggravates hypoglycemia and that is related to a completely unknown mechanism, which reduces the concentration of glucose in the blood system.
He also clarified that the improvement in blood sugar levels is independent of weight loss.
The scientists concluded that the brain influences the amount of glucose in the blood and that the injection of the FGF1 hormone leads to changes in this that must be taken into account for future research.
Source: EFE
